Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cologuard
Cologuard
Exact Sciences’ next-gen colorectal cancer test hits primary goals in pivotal study
Exact Sciences’ next-gen colorectal cancer test hits primary goals in pivotal study
Medtech Dive
EXACT Sciences
Medtech
diagnostics
colorectal cancer
Cologuard
clinical trials
Flag link:
Exact Sciences Should Benefit from Pfizer’s News Today
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Pfizer
colorectal cancer
EXACT Sciences
FDA
Braftovi
Cologuard
Flag link:
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Yahoo/Zacks.com
EXACT Sciences
Cologuard
diagnostics
colorectal cancer
Flag link:
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
Flag link:
Why Exact Sciences Stock Sank Today
Why Exact Sciences Stock Sank Today
Motley Fool
EXACT Sciences
Affordable Care Act
Cologuard
Flag link:
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround
Xconomy
EXACT Sciences
Kevin Conroy
diagnostics
colorectal cancer
Cologuard
Flag link:
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More
Yahoo/Motley Fool
EXACT Sciences
earnings
Cologuard
Flag link:
4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test
4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test
Motley Fool
23andMe
EXACT Sciences
diagnostics
colorectal cancer
Cologuard
Flag link:
Behind the Exact Sciences/Pfizer Cologuard co-promotion deal
Behind the Exact Sciences/Pfizer Cologuard co-promotion deal
Medical Marketing and Media
Pfizer
EXACT Sciences
Cologuard
diagnostics
colon cancer
Flag link:
Exact Sciences signs marketing deal with Pfizer for cancer test
Exact Sciences signs marketing deal with Pfizer for cancer test
Yahoo/Reuters
Pfizer
EXACT Sciences
Cologuard
diagnostics
colon cancer
Flag link:
Why Exact Sciences Shares Are Rallying 13.8% in 2018
Why Exact Sciences Shares Are Rallying 13.8% in 2018
Motley Fool
EXACT Sciences
colon cancer
American Cancer Society
Cologuard
Flag link:
20 Million More Potential Customers for Cologuard
20 Million More Potential Customers for Cologuard
Motley Fool
EXACT Sciences
colorectal cancer
Cologuard
diagnostics
Flag link:
Exact Sciences Needs New Study to Fully Benefit From ACS Change
Exact Sciences Needs New Study to Fully Benefit From ACS Change
Xconomy
EXACT Sciences
colorectal cancer
American Cancer Society
Cologuard
Flag link:
2 Reasons Exact Sciences Investors Shouldn't Worry -- and 1 Reason They Should
2 Reasons Exact Sciences Investors Shouldn't Worry -- and 1 Reason They Should
Motley Fool
EXACT Sciences
earnings
Cologuard
Flag link:
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales
Exact Sciences: Severe Flu Season Slows Down Cancer Test’s Sales
Xconomy
EXACT Sciences
Cologuard
Flu
diagnostics
Flag link:
Exact Looks to Sales Force, Ads to Boost Cancer Test Sales in 2018
Exact Looks to Sales Force, Ads to Boost Cancer Test Sales in 2018
Xconomy
EXACT Sciences
hirings
drug ads
Cologuard
Flag link:
Exact Sciences soars on colon cancer test ruling
Exact Sciences soars on colon cancer test ruling
Yahoo/AP
EXACT Sciences
colon cancer
Cologuard
diagnostics
Flag link:
Medicare Recommends $500 Reimbursement for Exact Sciences' Colon Cancer Test
Medicare Recommends $500 Reimbursement for Exact Sciences' Colon Cancer Test
TheStreet.com
Medicare
EXACT Sciences
Cologuard
colon cancer
Chembio Diagnostics
Flag link:
Most Popular News Headlines For Monday, August 11 2014
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Flag link:
Most popular news headlines for Monday, August 11 2014
Celltrion
Remsima
Jannsen
Remicade
Invokamet
JNJ
Sanofi
Cologuard
MannKind
Afrezza
EXACT Sciences
Flag link:
Pages
1
2
next ›
last »